Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing.
Biomolecules. 2021 Oct 22;11(11):1572. doi: 10.3390/biom11111572.
Biomolecules. 2021.
PMID: 34827570
Free PMC article.
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
Van Hemelryk A, Tomljanovic I, de Ridder CMA, Stuurman DC, Teubel WJ, Erkens-Schulze S, Verhoef EI, Remmers S, Mahes AJ, van Leenders GJLH, van Royen ME, van de Werken HJG, Grudniewska M, Jenster GW, van Weerden WM.
Van Hemelryk A, et al.
Cells. 2022 Nov 16;11(22):3632. doi: 10.3390/cells11223632.
Cells. 2022.
PMID: 36429059
Free PMC article.
Item in Clipboard
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
Van Hemelryk A, Erkens-Schulze S, Lim L, de Ridder CMA, Stuurman DC, Jenster GW, van Royen ME, van Weerden WM.
Van Hemelryk A, et al.
Cells. 2023 May 12;12(10):1377. doi: 10.3390/cells12101377.
Cells. 2023.
PMID: 37408211
Free PMC article.
Item in Clipboard
Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.
Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van 't Geloof S, Teubel WJ, Koolen SLW, Martens-Uzunova ES, van Royen ME, de Wit R, Mathijssen RHJ, van Weerden WM.
Buck SAJ, et al. Among authors: van hemelryk a.
Mol Cancer Ther. 2024 May 2;23(5):711-720. doi: 10.1158/1535-7163.MCT-23-0420.
Mol Cancer Ther. 2024.
PMID: 38030379
Item in Clipboard
The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 Patients.
Van Hemelryk A, De Meerleer G, Ost P, Poelaert F, De Gersem W, Decaestecker K, De Visschere P, Fonteyne V.
Van Hemelryk A, et al.
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):323-332. doi: 10.1016/j.ijrobp.2016.06.011. Epub 2016 Jun 16.
Int J Radiat Oncol Biol Phys. 2016.
PMID: 27598803
Clinical Trial.
Item in Clipboard
Cite
Cite